817 related articles for article (PubMed ID: 19479202)
21. Dendritic cell immunobiology and potential roles in immunotherapy.
Fadilah SA; Cheong SK
Malays J Pathol; 2007 Jun; 29(1):1-18. PubMed ID: 19108040
[TBL] [Abstract][Full Text] [Related]
22. Dendritic cell-based vaccines in breast and gynaecologic cancer.
Hernando JJ; Park TW; Kuhn WC
Anticancer Res; 2003; 23(5b):4293-303. PubMed ID: 14666641
[TBL] [Abstract][Full Text] [Related]
23. Mechanisms of dendritic cell-based vaccination against infection.
Fajardo-Moser M; Berzel S; Moll H
Int J Med Microbiol; 2008 Jan; 298(1-2):11-20. PubMed ID: 17719274
[TBL] [Abstract][Full Text] [Related]
24. [Dendritic cells and their applications in cancer immunotherapy--achievements and future prospects].
Rossowska J; Pajtasz-Piasecka E
Postepy Hig Med Dosw; 2003; 57(5):501-18. PubMed ID: 14737967
[TBL] [Abstract][Full Text] [Related]
25. Dendritic cell-derived exosomes in cancer immunotherapy: exploiting nature's antigen delivery pathway.
Delcayre A; Shu H; Le Pecq JB
Expert Rev Anticancer Ther; 2005 Jun; 5(3):537-47. PubMed ID: 16001959
[TBL] [Abstract][Full Text] [Related]
26. Loading DCs with Ag.
Vari F; Hart DN
Cytotherapy; 2004; 6(2):111-21. PubMed ID: 15203987
[TBL] [Abstract][Full Text] [Related]
27. Advances in specific immunotherapy for prostate cancer.
Kiessling A; Füssel S; Wehner R; Bachmann M; Wirth MP; Rieber EP; Schmitz M
Eur Urol; 2008 Apr; 53(4):694-708. PubMed ID: 18061335
[TBL] [Abstract][Full Text] [Related]
28. Dendritic cells in cancer immunotherapy.
Gunzer M; Grabbe S
Crit Rev Immunol; 2001; 21(1-3):133-45. PubMed ID: 11642600
[TBL] [Abstract][Full Text] [Related]
29. Enhancing the clinical activity of granulocyte-macrophage colony-stimulating factor-secreting tumor cell vaccines.
Jinushi M; Hodi FS; Dranoff G
Immunol Rev; 2008 Apr; 222():287-98. PubMed ID: 18364009
[TBL] [Abstract][Full Text] [Related]
30. Dendritic cell vaccination induces tumor epitope-specific Th1 immune response in medullary thyroid carcinoma.
Papewalis C; Wuttke M; Jacobs B; Domberg J; Willenberg H; Baehring T; Cupisti K; Raffel A; Chao L; Fenk R; Seissler J; Scherbaum WA; Schott M
Horm Metab Res; 2008 Feb; 40(2):108-16. PubMed ID: 18283628
[TBL] [Abstract][Full Text] [Related]
31. Dendritic cell-based tumor vaccines and antigen presentation attenuators.
Evel-Kabler K; Chen SY
Mol Ther; 2006 May; 13(5):850-8. PubMed ID: 16574490
[TBL] [Abstract][Full Text] [Related]
32. Dendritic cells as vectors for immunotherapy of tumor and its application for gastric cancer therapy.
Wu Y; Wang L; Zhang Y
Cell Mol Immunol; 2004 Oct; 1(5):351-6. PubMed ID: 16285894
[TBL] [Abstract][Full Text] [Related]
33. Current issues in dendritic cell cancer immunotherapy.
López JA; Hart DN
Curr Opin Mol Ther; 2002 Feb; 4(1):54-63. PubMed ID: 11885565
[TBL] [Abstract][Full Text] [Related]
34. Receptor-mediated delivery of antigens to dendritic cells: anticancer applications.
Proudfoot O; Apostolopoulos V; Pietersz GA
Mol Pharm; 2007; 4(1):58-72. PubMed ID: 17228857
[TBL] [Abstract][Full Text] [Related]
35. Dendritic cell-based vaccines: from mouse models to clinical cancer immunotherapy.
Schreurs MW; Eggert AA; Punt CJ; Figdor CG; Adema GJ
Crit Rev Oncog; 2000; 11(1):1-17. PubMed ID: 10795625
[TBL] [Abstract][Full Text] [Related]
36. Dendritic cell-based cancer vaccination: quo vadis?
Dauer M; Schnurr M; Eigler A
Expert Rev Vaccines; 2008 Sep; 7(7):1041-53. PubMed ID: 18767953
[TBL] [Abstract][Full Text] [Related]
37. Advances in dendritic cell-based vaccine of cancer.
Zhang X; Gordon JR; Xiang J
Cancer Biother Radiopharm; 2002 Dec; 17(6):601-19. PubMed ID: 12537664
[TBL] [Abstract][Full Text] [Related]
38. DCs and CD40-activated B cells: current and future avenues to cellular cancer immunotherapy.
Schultze JL; Grabbe S; von Bergwelt-Baildon MS
Trends Immunol; 2004 Dec; 25(12):659-64. PubMed ID: 15530836
[TBL] [Abstract][Full Text] [Related]
39. Potentiation strategies of dendritic cell-based antitumor vaccines: combinational therapy takes the front seat.
Torabi-Rahvar M; Bozorgmehr M; Jeddi-Tehrani M; Zarnani AH
Drug Discov Today; 2011 Aug; 16(15-16):733-40. PubMed ID: 21558016
[TBL] [Abstract][Full Text] [Related]
40. Induction of protective CTL immunity against peptide transporter TAP-deficient tumors through dendritic cell vaccination.
Chambers B; Grufman P; Fredriksson V; Andersson K; Roseboom M; Laban S; Camps M; Wolpert EZ; Wiertz EJ; Offringa R; Ljunggren HG; van Hall T
Cancer Res; 2007 Sep; 67(18):8450-5. PubMed ID: 17875682
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
